Triad of Ascending Cholangitis
The classic triad of ascending cholangitis, known as Charcot's triad, consists of fever (with or without chills), right upper quadrant abdominal pain, and jaundice. 1, 2, 3, 4
Clinical Presentation
Charcot's Triad (Classic Presentation)
The three cardinal features that define acute cholangitis are:
- Fever and/or chills - the most common presenting symptom 1, 2, 4
- Right upper quadrant or epigastric abdominal pain 1, 2, 4
- Jaundice - indicating biliary obstruction 1, 2, 4
A definitive diagnosis can be made even when not all components of Charcot's triad are present, provided laboratory data and imaging findings support evidence of inflammation and biliary obstruction. 4
Reynolds' Pentad (Severe Disease)
When cholangitis progresses to severe disease with septic shock, two additional features may appear:
This five-component presentation (Reynolds' pentad) indicates life-threatening disease requiring urgent intervention. 5
Diagnostic Workup
Laboratory Findings
Cholestatic liver biochemistry is the hallmark laboratory pattern, characterized by:
- Elevated alkaline phosphatase (ALP) - most common biochemical abnormality 6, 2, 7
- Elevated γ-glutamyl transpeptidase (GGT) 6, 7
- Elevated serum bilirubin (both direct and indirect) 7
- Elevated AST and ALT (typically 2-3 times upper limit of normal) 2, 7
- Elevated inflammatory markers (CRP, procalcitonin, lactate) in critically ill patients 7
Imaging Studies
Abdominal ultrasound should be the initial imaging modality to assess for biliary obstruction, though it may be normal in early disease. 1, 2
For definitive diagnosis and characterization of biliary obstruction:
- Abdominal triphasic CT is recommended as first-line diagnostic imaging to detect ductal dilation and intra-abdominal collections 7
- Contrast-enhanced MRCP provides exact visualization, localization, and classification of biliary obstruction 7
- ERCP may be both diagnostic and therapeutic, allowing for immediate biliary drainage 8
Management Algorithm
Immediate Medical Management
All patients require prompt initiation of:
- Intravenous fluid resuscitation 3, 9
- Broad-spectrum antibiotic therapy within 1 hour for septic patients, within 6 hours for less severe cases 8
For non-critically ill, immunocompetent patients: Amoxicillin/Clavulanate 2g/0.2g every 8 hours 7
For beta-lactam allergy: Eravacycline 1 mg/kg every 12 hours or Tigecycline 100 mg loading dose then 50 mg every 12 hours 7
For critically ill or immunocompromised patients: Piperacillin/tazobactam 6g/0.75g loading dose then 4g/0.5g every 6 hours or 16g/2g by continuous infusion 7
Biliary Drainage Strategy
The timing and method of biliary drainage depends on disease severity:
Severe (Grade III) Cholangitis
Moderate (Grade II) Cholangitis
- Requires early biliary drainage within 24 hours 8
- Does not respond to initial medical treatment but without organ dysfunction 4
- Early drainage (<24 hours) significantly reduces 30-day mortality 8
Mild (Grade I) Cholangitis
- Can be initially observed on medical treatment 8, 4
- Responds to initial medical therapy 4
- Elective drainage can be performed after clinical stabilization 8
Drainage Modality Selection
Endoscopic transpapillary biliary drainage (ERCP with stent placement) is the first-line procedure for biliary decompression, as it is safer and more effective than percutaneous or surgical approaches. 8, 5
The focus in severe biliary sepsis should be on biliary decompression rather than definitive treatment, with minimal manipulation of the biliary tree. 8
Percutaneous transhepatic biliary drainage (PTBD) should be reserved for cases where endoscopic approaches fail or are not feasible. 8
Open surgical drainage is currently extremely rare due to widespread availability of endoscopic and percutaneous techniques. 8
Common Pitfalls
Do not delay biliary drainage in moderate or severe cholangitis - antibiotics alone are insufficient when biliary obstruction persists, as cholangitis cannot occur without obstruction. 8
Recognize that episodes of cholangitis are uncommon at initial presentation of PSC unless there has been prior biliary surgery or instrumentation. 2 This helps distinguish primary from secondary sclerosing cholangitis.
Be aware that not all patients present with complete Charcot's triad - diagnosis can still be made with supporting laboratory and imaging findings. 4
After resolution of sepsis, definitive treatment of the underlying cause (such as choledocholithiasis, strictures, or malignancy) is necessary to prevent recurrence. 7